Citizens Financial Group Inc Amgen Inc Transaction History

Citizens Financial Group Inc

$4.47 Billion
Q2 2024

A detailed history of Citizens Financial Group Inc transactions in Amgen Inc stock. As of the latest transaction made, Citizens Financial Group Inc holds 14,218 shares of AMGN stock, worth $4.58 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

14,218

Previous 11,062 28.53%

Holding current value

$4.58 Million

Previous $3.15 Million 41.24%

% of portfolio

0.1%

Previous 0.11%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$262.75 - $319.31 $829,239 - $1.01 Million	3,156 Added 28.53%	14,218 $4.44 Million
Q1 2024 May 17, 2024	SELL	$268.87 - $324.56 $236,874 - $285,937	-881 Reduced 7.38%	11,062 $3.15 Million
Q4 2023 Feb 02, 2024	BUY	$255.7 - $288.46 $241,125 - $272,017	943 Added 8.57%	11,943 $3.44 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $1.29 Million - $1.61 Million	-5,917 Reduced 34.98%	11,000 $2.96 Million
Q2 2023 Aug 04, 2023	SELL	$214.27 - $253.37 $207,199 - $245,008	-967 Reduced 5.41%	16,917 $3.76 Million
Q1 2023 May 10, 2023	BUY	$225.79 - $275.2 $135,925 - $165,670	602 Added 3.48%	17,884 $4.32 Million
Q4 2022 Feb 09, 2023	SELL	$229.03 - $291.01 $139,479 - $177,225	-609 Reduced 3.4%	17,282 $4.54 Million
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $35,689 - $40,250	-159 Reduced 0.88%	17,891 $4.03 Million
Q2 2022 Aug 05, 2022	SELL	$230.71 - $256.74 $90,669 - $100,898	-393 Reduced 2.13%	18,050 $4.39 Million
Q1 2022 May 12, 2022	SELL	$219.27 - $242.57 $422,752 - $467,674	-1,928 Reduced 9.46%	18,443 $4.46 Million
Q4 2021 Feb 10, 2022	SELL	$198.88 - $227.6 $104,014 - $119,034	-523 Reduced 2.5%	20,371 $4.48 Million
Q3 2021 Nov 05, 2021	SELL	$212.27 - $248.7 $3.8 Million - $4.45 Million	-17,904 Reduced 46.15%	20,894 $4.44 Million
Q2 2021 Aug 04, 2021	SELL	$233.58 - $259.14 $4.92 Million - $5.46 Million	-21,067 Reduced 35.19%	38,798 $9.46 Million
Q1 2021 May 14, 2021	SELL	$221.91 - $258.6 $39,499 - $46,030	-178 Reduced 0.3%	59,865 $14.9 Million
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $178,080 - $212,062	-823 Reduced 1.35%	60,043 $13.8 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $4.13 Million - $4.59 Million	-17,589 Reduced 22.42%	60,866 $15.5 Million
Q2 2020 Aug 12, 2020	SELL	$197.81 - $242.74 $139,258 - $170,888	-704 Reduced 0.89%	78,455 $18.5 Million
Q1 2020 May 08, 2020	BUY	$182.24 - $241.7 $2.89 Million - $3.83 Million	15,852 Added 25.04%	79,159 $16 Million
Q4 2019 Feb 07, 2020	SELL	$189.21 - $243.2 $289,680 - $372,339	-1,531 Reduced 2.36%	63,307 $15.3 Million
Q3 2019 Nov 01, 2019	SELL	$174.11 - $208.62 $153,390 - $183,794	-881 Reduced 1.34%	64,838 $12.5 Million
Q2 2019 Aug 09, 2019	SELL	$166.7 - $195.41 $388,744 - $455,696	-2,332 Reduced 3.43%	65,719 $12.1 Million
Q1 2019 May 09, 2019	BUY	$180.87 - $203.88 $75,965 - $85,629	420 Added 0.62%	68,051 $12.9 Million
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $129,161 - $150,773	-724 Reduced 1.06%	67,631 $13.2 Million
Q3 2018 Nov 02, 2018	SELL	$185.29 - $208.89 $175,099 - $197,401	-945 Reduced 1.36%	68,355 $14.2 Million
Q2 2018 Jul 27, 2018	SELL	$166.05 - $186.51 $225,994 - $253,840	-1,361 Reduced 1.93%	69,300 $12.8 Million
Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $405,954 - $474,408	-2,396 Reduced 3.28%	70,661 $12 Million
Q4 2017 Feb 09, 2018	BUY	$168.79 - $188.59 $162,882 - $181,989	965 Added 1.34%	73,057 $12.7 Million
Q3 2017 Nov 13, 2017	SELL	$167.29 - $191.0 $298,779 - $341,126	-1,786 Reduced 2.42%	72,092 $13.4 Million
Q2 2017 Aug 10, 2017	BUY	N/A	73,878	73,878 $12.7 Million

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citizens Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citizens Financial Group Inc with notifications on news.

Account

Citizens Financial Group Inc Amgen Inc Transaction History